Skip to content
Home/Companies/MedTech/Astraveus
Astraveus

Astraveus

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Astraveus?

Astraveus is currently owned by AdBio Partners through AFB Fund II (2021 vintage), since 2023.

Hand-verified · updated 2026-04-21

AdBio Partners
Investor
AdBio Partners
AFB Fund II · 2021 · VC

Key facts

HQFrance
SectorMedTech
Websitewww.astraveus.com

More from AFB Fund II

Other portfolio companies in the same fund.

Orikine Bio
Active
BiotechSpain· 2026
AndzonBio2
AndzonBio2
Active
BiotechFrance· 2025
Cephagenix
Cephagenix
Active
BiotechDenmark· 2025
EvlaBio
Active
BiotechGermany· 2025
AndzonBio1
AndzonBio1
Active
BiotechFrance· 2024
Anoat Therapeutics
Active
BiotechFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Astraveus

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Astraveus?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Astraveus.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue